RPAM
TMDX icon

Rhenman & Partners Asset Management’s Transmedics TMDX Stock Holding History

Rhenman & Partners Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-38,000
Closed -$2.37M – 102
2024
Q4 		$2.37M Sell
38,000
-7,270
-16% -$677K 0.24% 76
2024
Q3 		$7.11M Buy
45,270
+31,770
+235% +$4.9M 0.58% 55
2024
Q2 		$2.03M Buy
+13,500
New +$1.62M 0.2% 75

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rhenman & Partners Asset Management's TMDX Position: Q1 2025 in Review

Rhenman & Partners Asset Management sold out of Transmedics (TMDX) in Q1 2025, closing a stake of 38,000 shares — an estimated $2.37M sold.

Rhenman & Partners Asset Management first reported a position in TMDX in Q2 2024 and held it in 3 quarters. The position peaked at $7.11M in Q3 2024. 298 funds tracked by Wall St. Rank hold TMDX as of Q1 2025.

  • Rhenman & Partners Asset Management reported no remaining Transmedics position as of Q1 2025 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 38,000 Transmedics shares in Q1 2025, an estimated $2.37M.
  • Rhenman & Partners Asset Management first reported a position in Transmedics in Q2 2024 and held it in 3 quarters.
  • Rhenman & Partners Asset Management's Transmedics position peaked at $7.11M in Q3 2024.
  • 298 funds tracked by Wall St. Rank held Transmedics as of Q1 2025.

Based on Rhenman & Partners Asset Management's 13F filing for Q1 2025, filed 14 May 2025.